Search filters

List of works by Livio Garattini

'Appropriateness' in Italy: A 'Magic Word' in Pharmaceuticals?

scientific article published on 01 February 2017

A critical review of the full economic evaluations of pharmacological treatments for colorectal cancer.

scientific article published on January 2008

A critical review of the full economic evaluations of pharmacological treatments for glaucoma.

scientific article published on January 2008

A review of the costs of managing childhood epilepsy

scientific article

Access to primary care in Italy: time for a shake-up?

scientific article published on 01 March 2016

Biosimilar versus generic drugs: same but different?

scientific article published on 01 April 2015

Budget impact analysis in economic evaluation: a proposal for a clearer definition

scientific article published on 01 December 2011

Clinical Governance in Italy: 'Made in England' for Import?

scientific article published on 01 October 2017

Comment on: "Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers"

scientific article published on 01 October 2014

Comment on: 'NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence'

scientific article published on 01 January 2020

Comment on: 'The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study'

scientific article published on 01 October 2019

Comment on: 'Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition'

scientific article published on 03 February 2020

Community and hospital pharmacists in Europe: encroaching on medicine?

scientific article published on 13 September 2020

Competition in pharmaceuticals: more product- than price-oriented?

scientific article published on 9 October 2017

Conflict of interest disclosure: striking a balance?

scientific article published on 01 July 2019

Conflicts of interest in medicine: a never-ending story

scientific article published on 02 March 2020

Continuing Medical Education in six European countries: a comparative analysis

scientific article published on 12 November 2009

Correction to: Defensive medicine in Europe: a 'full circle'?

scientific article published on 01 July 2020

Cost minimisation analysis of 12 or 24 weeks of peginterferon alfa-2b + ribavirin for hepatitis C virus

scientific article published in January 2008

Could co-payments on drugs help to make EU health care systems less open to political influence?

scientific article published on 01 October 2013

Curing cervical cancer or preventing it: A case of opportunity cost in the long run?

scientific article published on 25 October 2014

Defensive medicine in Europe: a 'full circle'?

scientific article published on 26 December 2019

Defensive medicine in Europe: a 'full circle'?

scientific article published on 09 January 2020

Defensive medicine: Everything and its opposite

scientific article published on 28 January 2020

Direct cost of medical management of epilepsy among adults in Italy: a prospective cost-of-illness study (EPICOS).

scientific article

Direct costs of schizophrenia and related disorders in Italian community mental health services: a multicenter, prospective 1-year followup study

scientific article published in January 2004

Direct medical costs of age-related macular degeneration in Italian hospital ophthalmology departments

article

Direct medical costs of age-related macular degeneration in Italian hospital ophthalmology departments. A multicenter, prospective 1-year study

scientific article published in February 2004

Direct medical costs of monitoring and treating patients with Takayasu arteritis in Italy

scientific article published on 01 December 2004

Direct medical costs of mycosis fungoides in specialized Italian hospital departments

scientific article published on 01 February 2005

Direct medical costs unequivocally related to diabetes in Italian specialized centers

scientific article published in February 2004

Do European pharmacists really have to trespass on medicine?

scientific article published on 11 April 2020

Economic Evidence of Pneumococcal Vaccination in Older Adults: Uncertain Modelling or Competitive Tendering?

scientific article

Economic evaluation of human papilloma virus vaccination in the European Union: a critical review

scientific article published on 11 February 2011

Economic evaluations in Italy: a review of the literature

scientific article published on January 2003

HPV vaccine prices in Italy

scientific article published on 18 October 2011

HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?

Health status, resource consumption, and costs of dysthymia. A multi-center two-year longitudinal study

scientific article published on 13 December 2005

Health status, resource consumption, and costs of dysthymic patients in Italian primary care.

scientific article published in April 2004

Health technology assessment for pharmaceutical regulation in the European Union: do we need another body?

scientific article published on 15 November 2019

Health technology assessment: for whom the bell tolls?

scientific article published on 01 November 2008

Healthcare costs of COPD in Italian referral centres: a prospective study

scientific article published on 6 August 2007

Improving primary care in Europe beyond COVID-19: from telemedicine to organizational reforms

scientific article published on 16 November 2020

Influenza vaccine for healthy adult workers: an issue for health authorities or employers?

scientific article published on 19 November 2010

Integrative Review of Managed Entry Agreements: Chances and Limitations

scientific article published on 31 July 2020

Italian risk-sharing agreements on drugs: are they worthwhile?

scientific article published on 01 January 2015

Management of vaccinations in Italy: a national survey after healthcare regionalization

scientific article published on 07 July 2011

Medical costs of chronic musculoskeletal pain in Italy

scientific article published in January 2007

Medical costs of glaucoma and ocular hypertension in Italian referral centres: a prospective study

scientific article published in January 2007

Modeling in pharmacoeconomic studies: funding sources and outcomes

scientific article published on July 2010

More room for telemedicine after COVID-19: lessons for primary care?

scientific article published on 24 November 2020

Multiple Criteria Decision Analysis in Health Technology Assessment for Drugs: Just Another Illusion?

scientific article published on 01 February 2018

Off-patent drugs in Italy. A short-sighted view?

scientific article published on 01 March 2006

Pain in primary care: an Italian survey

scientific article published on 8 September 2005

Patient empowerment in Europe: is no further research needed?

scientific article published on 01 June 2018

Performance-Based Agreements in Italy: 'Trendy Outcomes' or Mere Illusions?

scientific article published on 01 October 2016

Pharmaceutical care in Italy and other European countries: between care and commerce?

scientific article published on 03 November 2017

Pharmaceutical expenditure control in Europe: time to move from pricing to budgeting?

scientific article published on 20 December 2019

Pharmaceutical policy in Italy: Theory, politics and practice

scientific article published on 01 June 2006

Pharmaceutical policy in Italy: towards a structural change?

scientific article published on 01 April 2005

Pharmaceutical pricing conundrum: time to get rid of it?

scientific article published on 01 November 2018

Prices and distribution margins of in-patent drugs in pharmacy: a comparison in seven European countries

scientific article published on 10 October 2007

Pricing and reimbursement of in-patent drugs in seven European countries: a comparative analysis

scientific article published on 27 November 2006

Pricing human papillomavirus vaccines: lessons from Italy

scientific article published on 01 March 2012

Pricing of HPV Vaccines in Europe: Back to the Future?

scientific article published on 01 June 2018

Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness?

scientific article published on 01 May 2015

Pricing vaccines and drugs in Europe: worth differentiating?

scientific article published on 23 June 2020

Re: The health technology assessment of bivalent HPV vaccine Cervarix® in Italy

scientific article published on 25 January 2011

Regional HTA in Italy: Promising or confusing?

scientific article published on 09 November 2012

Regional tenders on biosimilars in Italy: an empirical analysis of awarded prices

scientific article published on 17 February 2014

Reimbursable drug classes and ceilings in Italy: why not only one?

scientific article published on 01 November 2016

Risk sharing agreements: What lessons from Italy?

scientific article published on March 24, 2011

The Italian NHS: What Lessons to Draw from COVID-19?

scientific article published on 26 May 2020

The puzzle of drug delivery in Italy: who wins?

scientific article published on 03 May 2016

To model or not to model: lessons from two vaccinations

scientific article published in June 2011

Urgent reforms for general practice in Italy

scientific article published on 20 April 2019

Utilities and QALYs in health economic evaluations: glossary and introduction

article

Utilization and costs of antiepileptic drugs in the elderly: still an unsolved issue

scientific article published on January 2009

Vaccination planning in Italy: increasing vaccines while reducing coverage?

scientific article published on 29 July 2016

Western European markets for biosimilar and generic drugs: worth differentiating

scientific article published on 01 September 2015

[Pharmacoeconomic evaluations on antipsychotics in schizophrenia: a review of the Italian studies]

scientific article published on 01 April 2006